Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use VyLibra safely and effectively. See full prescribing information for VyLibra. VyLibra® (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989
Medication labelWhy this: Advisory · dailymed-prescription
VyLibra tablets are indicated for use by females of reproductive potential to prevent pregnancy [see Clinical Studies (14)].
- generic_name
- norgestimate and ethinyl estradiol
- brand_name
- Inert
- product_names
- norgestimate and ethinyl estradiol, Inert
- ndc
- 50102-235, 50102-235-11, 50102-235-13
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en